|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 1.038,40 USD | +0,53% |
|
-2,37% | -3,38% |
| 16/01 | Bemoedigende start voor Novo's Wegovy-pil in afvalrace tegen Lilly | RE |
| 16/01 | Wegovy-pil van Novo noteert 3.071 voorschriften in de eerste dagen na lancering | RE |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | k/w-verhouding (Y) | Koers-boekwaarde (Y) | PEG (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Beurskap. / EBIT (Y) | Dividendrendement (Y) | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | 45.31x | 34.64x | 0.47x | 15.02x | 33.36x | 36x | 0,57% | 930 mld. | |
| 21.16x | 6.73x | 0.27x | 5.89x | 16.37x | 17.95x | 2,36% | 527 mld. | |
| 63.59x | 678.64x | 1.55x | 7.14x | 17.12x | 17.64x | 3,05% | 379 mld. | |
| 20.49x | 7.16x | 0.31x | 5.08x | 12.65x | 14.21x | 2,84% | 371 mld. | |
| 28.83x | 6.5x | 0.64x | 5.35x | 15.87x | 16.72x | 1,73% | 292 mld. | |
| 13.94x | 5.01x | 0.88x | 4.57x | 9.84x | 11.07x | 2,97% | 270 mld. | |
| 20x | 6.45x | 0.92x | 5.35x | 12.53x | 13.61x | 2,85% | 276 mld. | |
| 16.84x | 9.13x | 8.25x | 5.95x | 12.3x | 14.23x | 2,99% | 268 mld. | |
| 25.84x | 19.66x | 0.37x | 6.13x | 10.48x | 14.06x | 2,89% | 178 mld. | |
| 18.61x | 6.88x | 0.01x | 5.75x | 10.49x | 12.63x | 2,66% | 155 mld. | |
| 12.64x | 1.61x | 0.29x | 3.06x | 7.66x | 8.9x | 6,67% | 146 mld. | |
| 11.92x | 1.26x | 0.25x | 2.53x | 8.23x | 9.06x | 5,09% | 113 mld. | |
| 13.47x | 5.56x | -0.07x | 3.03x | 8.97x | 9.37x | 4,46% | 112 mld. | |
| 28.44x | 5.9x | -0.03x | 8.52x | 18.45x | 19.14x | -.--% | 112 mld. | |
| 13.44x | 5.07x | 0.12x | 2.68x | 7.73x | 9.05x | 3,57% | 97,55 mld. | |
| 31.69x | 6.88x | 2.98x | 10.19x | 19.99x | 21.36x | 3,08% | 85,93 mld. | |
| 46.41x | 6.83x | 1.39x | 11.28x | 37.12x | 39.04x | 0,45% | 59,15 mld. | |
| 42.44x | 1.17x | 0.57x | 2.64x | 9.85x | 27.87x | 3,94% | 50,71 mld. | |
| 87.04x | 1.24x | -0.74x | 1.59x | 7.61x | 13.54x | 0,27% | 47,31 mld. | |
| Gemiddelde | 29,58x | 42,96x | 0,97x | 5,88x | 14,56x | 17,13x | 2,76% | 235,27 mld. | |
| Gewogen gemiddelde per kap. | 30,34x | 69,53x | 1,04x | 7,51x | 17,67x | 19,55x | 2,39% |
- Beurs
- Aandelen
- Koers LLY
- Sector Eli Lilly and Company
- Sectorale waarderingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
